Myriad Genetics settles with BRCA test competitors
Myriad Genetics has settled litigation with competitors who had been using genetic testing for breast cancer genes...
A form of intellectual property. The owners of a patent are granted a temporary monopoly over an invention (a right to exclude others from making, using or selling it) in exchange for detailed public disclosure of the invention
Myriad Genetics has settled litigation with competitors who had been using genetic testing for breast cancer genes...
The European Court of Justice (CJEU) has cleared the way for the patenting of human parthenotes for industrial and commercial purposes, clarifying the definition of 'human embryo' excluded from patentability in European Law...
by Ross Cloney
'Everybody has the same damn list.' It was with these words that Peter Farley, one time president of the biotechnology firm, Cetus, described the early days of commercial molecular biology. This race to clone, express and commercialise human genes is the focus of Nicolas Rasmussen's book...
by BioNews
An unprecedented consortium of ten global pharmaceutical companies, the UK's Wellcome Trust, and five research institutes will pool their resources to draw up a $45m (£30m) map of the variations in the human genetic code, or single-nucleotide polymorphisms (SNPs). This alliance, called the SNP Consortium, also announced last week that...
BioNews, published by the Progress Educational Trust (PET), provides news and comment on genetics, assisted conception, embryo/stem cell research and related areas.